$HROW
Harrow, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$29.61
▼-2.98%-$0.910
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateHarrow, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is HROW down today? It is at $29.61 (-2.98%), and our scanner flagged it 86 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment HROW spikes, and full due diligence on HROW — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $HROW 86 times in the last 30 days. Create a free account to track $HROW, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on HROW from our scanner (live price and day move above). A recent catalyst in the news: “Do Options Traders Know Something About Harrow Stock We Don't?.” Early read: bearish.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Shojaei Amir Officer | Sold (automatic/other) | -11K 0.03% of company | n/a | n/a | $450K at $40.00 | Aug 14, 26 |
Shojaei Amir Officer | Other | 11K 0.03% of company | n/a | 11K | $405K at $35.96 | Aug 14, 26 |
Graves Adrienne L Director | Bought (open market) | +1K | n/a | 1K | $31K at $31.07 | May 18, 26 |
Silvernail Lauren P Director | Bought (open market) | +1K | n/a | 1K | $31K at $31.00 | May 18, 26 |
Boll Andrew R. Officer | Bought (open market) | +4K | added 0.4% | 815K | $105K at $29.90 | May 14, 26 |
Baum Mark L Officer | Bought (open market) | +10K 0.03% of company | added 0.3% | 3.00M | $302K at $30.20 | May 14, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Sold (automatic/other) | -138K 0.4% of company | sold 3.6% | 3.68M | $5.5M at $39.67 | Mar 4, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Sold (automatic/other) | -60K 0.2% of company | sold 49% | 64K | $2.4M at $39.15 | Mar 3, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Sold (automatic/other) | -5K 0.01% of company | sold 0.1% | 3.88M | $271K at $54.18 | Feb 27, 26 |
Opaleye Management Inc. Beneficial Owner (10%) | Sold (automatic/other) | -20K 0.05% of company | sold 0.5% | 3.88M | $1.1M at $53.35 | Jan 6, 26 |
Baum Mark L Officer | Sold (automatic/other) | -80K 0.2% of company | sold 2.6% | 2.99M | $3.8M at $47.06 | Dec 12, 25 |
Baum Mark L Officer | Other | 180K 0.5% of company | added 6.2% | 3.07M | $711K at $3.95 | Dec 12, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on HROW from our scanner (live price and day move above). A recent catalyst in the news: “Do Options Traders Know Something About Harrow Stock We Don't?.” Early read: bearish.
HROW last traded at $29.61, down 2.98% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Harrow, Inc. Common Stock (HROW) is next expected to report earnings on Monday, November 9, 2026, about 30 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The HROW Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged HROW 86 times in the last 30 days.
HROW (Harrow, Inc. Common Stock) trades on XNAS, with a market cap of about $1.10B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge HROW for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$HROW discussion
Sign in to ask a question or join the discussion.